Arrhythmias & electrophysiology

Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trial

Heart RhythmPublished randomized trial

Authors' conclusion

In CABANA patients without enlarged LAD, catheter ablation significantly reduced major cardiovascular events while the prognostic benefits of ablation diminished with atrial remodeling aggravation. Ablation at the initial stage of atrial remodeling provided an effective early rhythm control strategy to reduce cardiovascular risk in AF.

Study context

Population
Patients with atrial fibrillation (AF) in the CABANA trial who underwent echocardiographic measurement for left atrial diameter (LAD) at baselinepatients with documented LAD at baseline (median LAD 44 mm), CABANA randomized 2204
Participants
1,130 patients
Comparison
Ablation vs drug therapy, across extents of atrial remodeling
  • Ablationn = 570
  • Drug therapyn = 560reference
Primary endpoint
Composite of:
  • Death
  • Disabling stroke
  • Serious bleeding
  • Cardiac arrest
Methodological detailspost hoc analysis of patients with baseline echocardiographic LAD
  • Post hoc analysis of patients with baseline echocardiographic LAD

Primary result

As reported in the abstract

ablation vs drug therapyAdjusted hazard ratio (95% CI)
Patients without enlarged LAD (LAD ≤ 40 mm)
0.30(0.11–0.78)
Patients with enlarged LAD (LAD > 40 mm)
0.92(0.55–1.54)

Further findings

OutcomeAdjusted hazard ratio (95% CI)
Total mortalityAblationvs drug therapyPatients without enlarged LAD0.09 (0.01–0.58)
Total mortalityAblationvs drug therapyPatients with enlarged LAD0.76 (0.40–1.41)
  • Total mortality: interaction P = .045

Original publication

Impact of atrial remodeling on efficacy of catheter ablation in reducing cardiovascular risk in atrial fibrillation: Results from CABANA trial. Heart Rhythm. Published 16 April 2025. doi:10.1016/j.hrthm.2025.04.019

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.